Professor David Nicol

Consultant Urologist and Chief of Surgery MB BS FRACS

Specialism: Urology

Available at: Chelsea, Sutton

Special interests:

  • urological oncology
  • kidney cancer
  • testis cancer 
  • retroperitoneal/ adrenal tumours

Biography

Professor Nicol has both a private and an NHS practice at The Royal Marsden. He is a Consultant Urologist specialising in kidney and testis cancer as well as surgery for adrenal and retroperitoneal tumours. Prior to his appointment in 2012 he was Clinical Lead in Renal Transplantation at the Royal Free Hospital and Consultant Urologist at University College London Hospital, where he was responsible for surgery for all upper tract urological cancer.

Originally from Australia, he graduated from the University of Queensland in 1983 and after completion of urological training there undertook an American Society of Transplant Surgeons Fellowship in multi-organ transplantation in Canada. He returned to Australia and was appointed to Princess Alexandra Hospital as Director of Urology in 1992 and also Director of Renal Transplantation in 1994.

In Australia he pioneered laparoscopic urological surgery performing the first laparoscopic nephrectomy in 1993, and commenced laparoscopic live donor nephrectomy in 1999. He subsequently trained numerous urologists, including many from London and elsewhere in the UK, in laparoscopic renal surgery.

As an academic he was appointed as Senior Lecturer in Surgery at the University of Queensland in 1992 and Professor of Surgery in 2006. His research interests have included the development of xenograft models of kidney, testis and prostate cancer as well as generation of cell lines from urological malignancies. These have underpinned his research work in the role of tissue kallikriens in kidney, testis and prostate cancer with the identification of a number of tumour/tissue specific genes. To date he has published over 100 papers in peer reviewed journals and five book chapters as well as being a Chief Investigator for national and international grants in excess of £10 million.

At The Royal Marsden, where he is currently Chief of Surgery, his clinical work has focussed on retroperitoneal surgery for advanced testicular cancer and kidney cancer, including the establishment of a robotic renal surgery programme. He is a member of the Clinical Reference Group for Specialist Urological Cancer for NHS England.

Clinical units